Zuellig Pharma CEO John Graham has been appointed a member of the 2024 Board of the US-ASEAN Business Council, which steers regional shifts with research and analysis of economic, environmental, financial, political, and social conditions in the 10 nations of ASEAN.

In its 40th year in 2024, the US-ASEAN Business Council has spearheaded efforts that highlight regional gaps and opportunities across individual sectors such as biopharma and healthcare. Initiatives like white papers, dialogues and meetings help to engage key stakeholders on urgent issues.

As Zuellig Pharma drives efforts towards our key goals this year, meaningful dialogues and key insights from stakeholders can strengthen directives that can elevate healthcare strains across the region.